Amedica (AMDA) Tops Q3 EPS, Revenue Expectations

Amedica (NASDAQ: AMDA) reported Q3 EPS of ($0.39), $0.12 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $6 million versus the consensus estimate of $5.95 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Stardust Power (SDST) Tops Q2 EPS by 1c
• Workhorse Group (WKHS) Misses Q2 EPS by 77c